MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03580cam a2200229 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780323550642 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220107t2019 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323550642 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323479271 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wallace, Daniel J. |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Dubois' lupus erythematosus and related syndromes |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
9th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Edinburgh : |
| Name of publisher, distributor, etc. |
Elsevier, |
| Date of publication, distribution, etc. |
2019 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xv, 800 pages) |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
History of lupus -- Definition and classification of lupus and lupus-related disorders -- The epidemiology of lupus -- Overview of lupus pathogenesis -- Genetics of human SLE -- Epigenetics of lupus -- The environment and the host -- The innate immune system in SLE -- B cells and generation of antibodies -- T cells -- Adaptive and innate immunoregulatory cells -- Cytokines in lupus -- Immunometabolism -- Animal models in lupus -- Abnormalities in immune complex clearance and apoptotic cell clearance -- The role of complement in SLE -- Apoptosis and inflammatory forms of cell death -- Tissue damage in lupus : free radicals and fibrosis -- Pathogenesis of fibrosis--the lung as a model -- Pathogenesis of lupus nephritis -- Pathogenesis of accelerated atherosclerosis and vascular injury in systemic lupus erythematosus -- Pathogenesis of cutaneous lupus -- Pathogenesis of neuropsychiatric lupus -- Pathogenesis of antiphospholipid antibody syndrome -- Pathogenesis of SjoÌgren's -- Structure and derivation of autoantibodies -- Antinuclear antibodies, antibodies to DNA, histones, and nucleosomes -- Antibodies against ENA (SM, RNP, SSA, SSB) -- Antibodies against C1q -- Antilipoprotein and antiendothelial cell antibodies -- Drug-induced lupus erythematosus -- Overview and clinical presentation -- Skin disease in cutaneous lupus erythematosus -- The musculoskeletal system and bone metabolism -- Lupus and the cardiopulmonary system -- Lupus and the nervous system : clinical aspects, psychopathology, and imaging -- Gastrointestinal and hepatic systems -- Hematologic and lymphoid abnormalities in SLE -- Neonatal lupus : pathogenesis and clinical approaches -- Pregnancy and autoimmune disease, reproductive and hormonal issues -- Systemic lupus erythematosus in childhood and adolescence -- Clinical aspects of antiphospholipid syndrome -- Lupus and infections -- Ocular, aural, and oral manifestations of lupus -- Clinical aspects of SjoÌgren's -- Clinical application of serologic tests, serum protein abnormalities, and other clinical laboratory tests in systemic lupus erythematosus -- Differential diagnosis and disease associations -- Incomplete lupus, undifferentiated connective tissue disease, and mixed connective tissue disease -- Clinical markers, metrics, indices, and clinical trials -- Lupus biomarkers -- Principles of therapy, local measures, and NSAIDs -- Antimalarial medications -- Systemic glucocorticoid therapy for SLE -- Immunosuppressive drug therapy -- Complementary and alternative medications, specialized and niche therapies -- Adjunctive treatments and preventive measures -- Targeted therapies in SLE -- Management of cutaneous lupus erythematosus -- Epidemiology and management of lupus nephritis -- Management of SjoÌgren's -- Socioeconomic and disability aspects -- Prognosis and mortality of SLE." |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Systemic lupus erythematosus. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Lupus erythematosus. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hahn, Bevra |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20150067764">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20150067764</a> |